In 15% of patients with multiple myeloma (MM), a hematological disease characterized by the accumulation of malignant plasma cells in the bone marrow, cyclin D1 is aberrantly expressed as a result of the t(11;14)(q13;q32) translocation in [14]. The gene discussed is CCND1; the disease is plasma cell myeloma.